Insider · CIK 0001632384
Galante Joseph C
Reports to the SEC for 3 companies · NASHVILLE, TN
Transactions
50
Companies
3
Filings
10
CIK
0001632384
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-03-18 | CPIXCUMBERLAND PHARMACEUTICALS INCA Award | +$5,040 |
| 2025-03-17 | CPIXCUMBERLAND PHARMACEUTICALS INCA Award | +$5,170 |
| 2024-03-25 | CPIXCUMBERLAND PHARMACEUTICALS INCA Award | +$4,275 |
| 2024-03-25 | CPIXCUMBERLAND PHARMACEUTICALS INCA Award | +$1,710 |
| 2024-03-01 | PNFPPINNACLE FINANCIAL PARTNERS INCA Award | — |
| 2024-03-01 | PNFPPINNACLE FINANCIAL PARTNERS INCF Tax Payment | −$19.8K |
| 2023-03-24 | CPIXCUMBERLAND PHARMACEUTICALS INCA Award | +$1,920 |
| 2023-03-01 | PNFPPINNACLE FINANCIAL PARTNERS INCA Award | — |
| 2023-03-01 | PNFPPINNACLE FINANCIAL PARTNERS INCF Tax Payment | −$12.9K |
| 2023-01-20 | PNFPPINNACLE FINANCIAL PARTNERS INCP Purchase | +$72.3K |
| 2022-12-21 | CPIXCUMBERLAND PHARMACEUTICALS INCP Purchase | +$399.6 |
| 2022-12-20 | CPIXCUMBERLAND PHARMACEUTICALS INCP Purchase | +$462 |
| 2022-12-19 | CPIXCUMBERLAND PHARMACEUTICALS INCP Purchase | +$552.5 |
| 2022-12-16 | CPIXCUMBERLAND PHARMACEUTICALS INCP Purchase | +$222 |
| 2022-12-15 | CPIXCUMBERLAND PHARMACEUTICALS INCP Purchase | +$134.4 |
| 2022-12-14 | CPIXCUMBERLAND PHARMACEUTICALS INCP Purchase | +$265.2 |
| 2022-12-13 | CPIXCUMBERLAND PHARMACEUTICALS INCP Purchase | +$261.6 |
| 2022-12-12 | CPIXCUMBERLAND PHARMACEUTICALS INCP Purchase | +$139.1 |
| 2022-12-09 | CPIXCUMBERLAND PHARMACEUTICALS INCP Purchase | +$139.75 |
| 2022-12-08 | CPIXCUMBERLAND PHARMACEUTICALS INCP Purchase | +$142.35 |
| 2022-12-07 | CPIXCUMBERLAND PHARMACEUTICALS INCP Purchase | +$141.7 |
| 2022-12-06 | CPIXCUMBERLAND PHARMACEUTICALS INCP Purchase | +$142.35 |
| 2022-12-05 | CPIXCUMBERLAND PHARMACEUTICALS INCP Purchase | +$142.35 |
| 2022-12-02 | CPIXCUMBERLAND PHARMACEUTICALS INCP Purchase | +$150.15 |
| 2022-12-01 | CPIXCUMBERLAND PHARMACEUTICALS INCP Purchase | +$151.45 |
| 2022-11-30 | CPIXCUMBERLAND PHARMACEUTICALS INCP Purchase | +$150.8 |
| 2022-11-29 | CPIXCUMBERLAND PHARMACEUTICALS INCP Purchase | +$152.1 |
| 2022-11-28 | CPIXCUMBERLAND PHARMACEUTICALS INCP Purchase | +$154.05 |
| 2022-11-25 | CPIXCUMBERLAND PHARMACEUTICALS INCP Purchase | +$150.15 |
| 2022-11-23 | CPIXCUMBERLAND PHARMACEUTICALS INCP Purchase | +$148.85 |
| 2022-11-22 | CPIXCUMBERLAND PHARMACEUTICALS INCP Purchase | +$154.05 |
| 2022-11-21 | CPIXCUMBERLAND PHARMACEUTICALS INCP Purchase | +$154.7 |
| 2022-11-18 | CPIXCUMBERLAND PHARMACEUTICALS INCP Purchase | +$147.55 |
| 2022-11-17 | CPIXCUMBERLAND PHARMACEUTICALS INCP Purchase | +$148.85 |
| 2022-11-16 | CPIXCUMBERLAND PHARMACEUTICALS INCP Purchase | +$150.15 |
| 2022-11-15 | CPIXCUMBERLAND PHARMACEUTICALS INCP Purchase | +$152.75 |
| 2022-11-14 | CPIXCUMBERLAND PHARMACEUTICALS INCP Purchase | +$150.8 |
| 2022-11-11 | CPIXCUMBERLAND PHARMACEUTICALS INCP Purchase | +$150.8 |
| 2022-11-10 | CPIXCUMBERLAND PHARMACEUTICALS INCP Purchase | +$154.05 |
| 2022-11-09 | CPIXCUMBERLAND PHARMACEUTICALS INCP Purchase | +$154.05 |
| 2022-11-08 | CPIXCUMBERLAND PHARMACEUTICALS INCP Purchase | +$157.3 |
| 2022-11-07 | CPIXCUMBERLAND PHARMACEUTICALS INCP Purchase | +$159.25 |
| 2022-11-04 | CPIXCUMBERLAND PHARMACEUTICALS INCP Purchase | +$157.3 |
| 2022-11-03 | CPIXCUMBERLAND PHARMACEUTICALS INCP Purchase | +$158.6 |
| 2022-11-02 | CPIXCUMBERLAND PHARMACEUTICALS INCP Purchase | +$165.1 |
| 2022-11-01 | CPIXCUMBERLAND PHARMACEUTICALS INCP Purchase | +$164.45 |
| 2022-10-31 | CPIXCUMBERLAND PHARMACEUTICALS INCP Purchase | +$165.1 |
| 2022-10-28 | CPIXCUMBERLAND PHARMACEUTICALS INCP Purchase | +$163.8 |
| 2022-10-27 | CPIXCUMBERLAND PHARMACEUTICALS INCP Purchase | +$161.85 |
| 2022-10-26 | CPIXCUMBERLAND PHARMACEUTICALS INCP Purchase | +$157.3 |
Recent filings
- 4Galante Joseph C0001632384-26-000002SEC(opens sec.gov)
- 4Galante Joseph C0001628280-25-013541SEC(opens sec.gov)
- 4/AGalante Joseph C0001628280-25-003185SEC(opens sec.gov)
- 4Galante Joseph C0001214659-24-005222SEC(opens sec.gov)
- 4Galante Joseph C0001115055-24-000054SEC(opens sec.gov)
- 4Galante Joseph C0001209191-23-021278SEC(opens sec.gov)
- 4Galante Joseph C0001567619-23-004174SEC(opens sec.gov)
- 4Galante Joseph C0001567619-23-001121SEC(opens sec.gov)
- 4Galante Joseph C0001209191-22-062651SEC(opens sec.gov)
- 4Galante Joseph C0001209191-22-062643SEC(opens sec.gov)
Companies
Address
1600 WEST END AVENUE SUITE 1300
NASHVILLE, TN, 37203